Protease inhibitors and cardiovascular outcomes in patients with HIV-1

Lancet

Volumn 360, Issue 9347, 2002, Pages 1747-1748

  Holmberg, Scott D ^a   Moorman, Anne C ^a   Williamson, John M ^a   Tong, Tony C ^a   Ward, Douglas J ^b   Wood, Kathy C ^c   Greenberg, Alan E ^a   Janssen, Robert S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Troy Thomas Dupont Circle Physicians Group   (United States)

^c Cerner Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY RISK; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; TREATMENT OUTCOME;

EID: 0037202854     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11672-2     Document Type: Article

References (5)

1. Palella F.J. Jr, Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 338:1998;853-860.
2. Passalaris J.D., Sepkowitz K.A., Glesby M.J. Coronary artery disease and human immunodeficiency virus infection. Clin Infect Dis. 31:2000;787-797.
3. Bozzette SA, Ake C, Carpenter A, et al. Cardio- and cerebrovascular outcomes with changing process of anti-HIV therapy in 36 766 US veterans. In: Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. Seattle: Feb 24-28, 2002 (abstr LB9). Alexandria: Foundation for Retrovirology and Human Health.
4. Henry K., Melroe H., Huebsch J., et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 351:1998;1328.
5. Barbaro G, Di Lorenzo G, Giancaspro G, et al. Incidence of coronary artery disease in HIV-infected patients receiving or not protease inhibitors: a randomized, multicenter study. Abstract book II: XIVth International Conference on AIDS. Barcelona: July 7-12, 2002 (abstr WeOrB1307). Barcelona: Prous Science.